Cargando…
Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
Pancreatic cancer is the fourth leading cause of cancer-related death in the USA and Europe; early symptoms and screenings are lacking, and it is usually diagnosed late with a poor prognosis. Circulating tumor cells (CTCs) have been promising new biomarkers in solid tumors. In the last twenty years...
Autores principales: | Martini, Verena, Timme-Bronsert, Sylvia, Fichtner-Feigl, Stefan, Hoeppner, Jens, Kulemann, Birte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895979/ https://www.ncbi.nlm.nih.gov/pubmed/31717773 http://dx.doi.org/10.3390/cancers11111659 |
Ejemplares similares
-
Cancer-associated Macrophage-like Cells in Patients with Non-metastatic Adenocarcinoma of the Esophagus - Cytomorphological Heterogeneity
por: Braun, Clara, et al.
Publicado: (2023) -
Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas
por: Kuvendjiska, Jasmina, et al.
Publicado: (2023) -
Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017) -
Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017) -
Non-Metastatic Esophageal Adenocarcinoma: Circulating Tumor Cells in the Course of Multimodal Tumor Treatment
por: Kuvendjiska, Jasmina, et al.
Publicado: (2019)